BlackRock, Vanguard, and other big asset managers are placing big bets on tech. But some advisers have major concerns about the new platforms.

Big asset managers like WisdomTree increasingly offer technology for financial advisors, raising conflict of interest questions and other concerns.

May 29, 2019   |   View Online »

BlackRock, Vanguard, and other big asset managers are placing big bets on tech. But some advisers have major concerns about the new platforms. Meghan Morris | Big asset managers like WisdomTree increasingly offer technology for financial advisors, raising conflict of interest questions and other concerns. Read More »

The CIO at a $70 billion private-equity behemoth explains how the rise of Amazon and Uber forced him to make a previously unthinkable change to his strategy Joe Ciolli | Jonathan Coslet, the chief investment officer of TPG Capital, tells how he changed his investing approach in response to the rise of Amazon and Uber. Read More »

A former Y Combinator partner says a founder's answer to this one question on the tech accelerator's application strongly predicts their startup success Shana Lebowitz | A former partner at Y Combinator would ask founders about their side projects. He realized curiosity outside of work was a big predictor of success. Read More »

Here's how much the typical healthcare employee makes, from CVS to buzzy biotechs Emma Court,Lydia Ramsey | The typical employee at some biotech companies makes north of $200,000 a year. While at CVS, the median pay is just over $35,000. Read More »

'This is a big swing': A New York Times exec explains the company's push into prestige TV that starts with 'The Weekly' on FX and Hulu Ashley Rodriguez | The executive behind The New York Times' new digital push explains how its TV show on FX and Hulu crystallizes the newsroom's transformation. Read More »

US consumers use cash less — but retailers still want to accept it Rachel Green | While cash usage is becoming less frequent among US consumers, merchants aren't ready to make the cashless switch just yet. Read More »

A top executive at Swiss drug giant Novartis told us the inside story of the $2.1 million price tag for the most expensive drug in the world Emma Court | The price tag creates "sticker shock." But Novartis says that because the disease is expensive to treat, the drug is worth it in the long run. Read More »

Andreessen Horowitz is famous for backing household names like Facebook and Lyft. Here's why it thinks it can do the same in biotech. Lydia Ramsey | Jorge Conde is backing biotech companies that he hopes will become giants in their own right rather than get acquired. Read More »

Inside The New York Times' unique deal with FX and Hulu for its TV show, 'The Weekly,' which could be a blueprint for others in the industry Ashley Rodriguez | The Times' first weekly news program will air on FX on Wednesdays, starting June 2, and Hulu hours later. It's the deal of the modern-TV era. Read More »

These 3 neuroscientists went from leading a hot startup to helping lead a key Intel initiative that could help it dominate the AI processor market as it heads for a showdown with Nvidia Benjamin Pimentel | Intel is trying to catch Nvidia in AI and is betting on three neuroscientists to develop Intel's first AI processor built from the ground up. Read More »

Share This Email    Read Business Insider On The Go

Email sent to: nguyenvu1187.love5@blogger.com Manage your email preferences   |   Unsubscribe Terms of Service   |   Privacy Policy Business Insider. 150 Fifth Ave, New York, NY 10011